Autor/in Eggemann, H 1 Eidtmann, H Fasching, P A 1 Hanusch, C 1 Kittel, K 1 Loibl, S 1 Rezai, M 1 Schrader, I Tesch, H 1 Untch, M 1 von Minckwitz, G 1 alle zeigenListe einklappen
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)† von Minckwitz, G Loibl, S Untch, M Eidtmann, H Rezai, M Fasching, P A Tesch, H 2014 - Forschungsinformationssystem des UKE
